Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James S Lotti

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Biorxiv : the Preprint Server for Biology|April 27, 2026
Native architecture, allosteric modulation and gating mechanism of glycine-dependent NMDA receptorsJunhoe Kim, Avery J Benton, James S Lotti, et al.
Brain Sciences|June 24, 2022
Synaptic Dysfunction by Mutations in <i>GRIN2B</i>: Influence of Triheteromeric NMDA Receptors on Gain-of-Function and Loss-of-Function Mutant ClassificationMarwa Elmasri, James S Lotti, Wajeeha Aziz, et al.
Journal of Medicinal Chemistry|December 17, 2021
Derivatives of (<i>R</i>)-3-(5-Furanyl)carboxamido-2-aminopropanoic Acid as Potent NMDA Receptor Glycine Site Agonists with GluN2 Subunit-Specific ActivityFabao Zhao, Unai Atxabal, Sofia Mariottini, et al.
Frontiers in Chemistry|December 5, 2022
Discovery of (<i>R</i>)-2-amino-3-triazolpropanoic acid derivatives as NMDA receptor glycine site agonists with GluN2 subunit-specific activityFabao Zhao, Georgios Mazis, Feng Yi, et al.
Journal of Natural Products|August 21, 2020
Isolation of Isotrichophycin C and Trichophycins G-I from a Collection of <i>Trichodesmium thiebautii</i>Kelly M McManus, Riley D Kirk, Christopher W Via, et al.
Molecular Pharmacology|February 7, 2025
Evaluation of allosteric N-methyl-d-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelingJames S Lotti, Jaron Jones, Jill C Farnsworth, et al.
Molecular Pharmacology|November 5, 2024
Evaluation of allosteric NMDA receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelingJames S Lotti, Jaron Jones, Jill C Farnsworth, et al.
The Journal of General Physiology|April 20, 2023
Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonistsNirvan Rouzbeh, Andrew R Rau, Avery J Benton, et al.
The Journal of General Physiology|December 3, 2025
Novel binding mode for negative allosteric NMDA receptor modulatorsJames S Lotti, Jed T Syrenne, Avery J Benton, et al.
Journal of Medicinal Chemistry|January 23, 2025
Design of (<i>R</i>)-3-(5-Thienyl)carboxamido-2-aminopropanoic Acid Derivatives as Novel NMDA Receptor Glycine Site Agonists: Variation in Molecular Geometry to Improve Potency and Augment GluN2 Subunit-Specific ActivityFabao Zhao, Unai Atxabal, Sofia Mariottini, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Biorxiv : the Preprint Server for Biology|April 27, 2026
Native architecture, allosteric modulation and gating mechanism of glycine-dependent NMDA receptorsJunhoe Kim, Avery J Benton, James S Lotti, et al.
Brain Sciences|June 24, 2022
Synaptic Dysfunction by Mutations in <i>GRIN2B</i>: Influence of Triheteromeric NMDA Receptors on Gain-of-Function and Loss-of-Function Mutant ClassificationMarwa Elmasri, James S Lotti, Wajeeha Aziz, et al.
Journal of Medicinal Chemistry|December 17, 2021
Derivatives of (<i>R</i>)-3-(5-Furanyl)carboxamido-2-aminopropanoic Acid as Potent NMDA Receptor Glycine Site Agonists with GluN2 Subunit-Specific ActivityFabao Zhao, Unai Atxabal, Sofia Mariottini, et al.
Frontiers in Chemistry|December 5, 2022
Discovery of (<i>R</i>)-2-amino-3-triazolpropanoic acid derivatives as NMDA receptor glycine site agonists with GluN2 subunit-specific activityFabao Zhao, Georgios Mazis, Feng Yi, et al.
Journal of Natural Products|August 21, 2020
Isolation of Isotrichophycin C and Trichophycins G-I from a Collection of <i>Trichodesmium thiebautii</i>Kelly M McManus, Riley D Kirk, Christopher W Via, et al.
Molecular Pharmacology|February 7, 2025
Evaluation of allosteric N-methyl-d-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelingJames S Lotti, Jaron Jones, Jill C Farnsworth, et al.
Molecular Pharmacology|November 5, 2024
Evaluation of allosteric NMDA receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modelingJames S Lotti, Jaron Jones, Jill C Farnsworth, et al.
The Journal of General Physiology|April 20, 2023
Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonistsNirvan Rouzbeh, Andrew R Rau, Avery J Benton, et al.
The Journal of General Physiology|December 3, 2025
Novel binding mode for negative allosteric NMDA receptor modulatorsJames S Lotti, Jed T Syrenne, Avery J Benton, et al.
Journal of Medicinal Chemistry|January 23, 2025
Design of (<i>R</i>)-3-(5-Thienyl)carboxamido-2-aminopropanoic Acid Derivatives as Novel NMDA Receptor Glycine Site Agonists: Variation in Molecular Geometry to Improve Potency and Augment GluN2 Subunit-Specific ActivityFabao Zhao, Unai Atxabal, Sofia Mariottini, et al.
Pageof 2